MUCINEX

Serial Number 98499792
688

Registration Progress

Application Filed
Apr 15, 2024
Under Examination
Dec 31, 2024
Approved for Publication
Nov 19, 2024
Published for Opposition
Nov 19, 2024
Registered

Trademark Image

MUCINEX

Basic Information

Serial Number
98499792
Filing Date
April 15, 2024
Published for Opposition
November 19, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
688
Status Date
Dec 31, 2024
Application
Pending
Classes
005

Rights Holder

RB Health (US) LLC

16
Address
399 Interpace Parkway
Parsippany, NJ 07054

Ownership History

RB Health (US) LLC

Original Applicant
16
Parsippany, NJ

RB Health (US) LLC

Owner at Publication
16
Parsippany, NJ

Legal Representation

Attorney
Mark Lerner, Esq.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description Documents
Jun 17, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 31, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 19, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 19, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 13, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 7, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 4, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 26, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 26, 2024 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Apr 15, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; preparations for the treatment of respiratory and pulmonary conditions; expectorants; anti-pyretic preparations, namely, pharmaceutical preparations for reducing fever; decongestants; cough suppressant; pharmaceutical antitussive-cold preparations; preparations for treating colds

Additional Information

Design Mark
The mark consists of the word "MUCINEX" imprinted on a three-dimensional product configuration of pink and white bi-layer tablet. The dashed lines depicting the oblong dosage tablet indicate placement of the mark on the goods and that the shape of the product is not claimed as part of the mark, and the dashed lines are not part of the mark.
Color Claim
The color(s) Pink and white is/are claimed as a feature of the mark.

Classification

International Classes
005